Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,161 | 10,973 | 17,870 | 23,185 | 10,629 |
| Marketable Securities | N/A | N/A | 3,175 | N/A | N/A |
| Receivables | 7,844 | 8,268 | 5,276 | 20,856 | 4,366 |
| Inventories | 17,974 | 28,604 | 27,780 | 25,999 | 18,186 |
| TOTAL | $37,129 | $50,346 | $55,753 | $72,616 | $35,480 |
| Non-Current Assets | |||||
| PPE Net | 35,352 | 36,018 | 34,909 | 35,906 | 32,789 |
| Intangibles | 125,938 | 128,439 | 120,838 | 123,976 | 115,597 |
| Other Non-Current Assets | 7,931 | 8,090 | 7,480 | 2,114 | 3,388 |
| TOTAL | $169,220 | $172,547 | $163,227 | $161,995 | $151,774 |
| Total Assets | $206,348 | $222,892 | $218,980 | $234,611 | $187,255 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,710 | 2,458 | 2,573 | 3,180 | 2,286 |
| Accounts payable and accrued liabilities | 21,579 | 22,624 | 23,107 | 20,753 | 17,568 |
| Other current liabilities | 1,151 | 1,219 | 1,466 | 1,487 | 1,667 |
| TOTAL | $25,681 | $26,994 | $27,786 | $26,301 | $22,324 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96,099 | 84,588 | 64,554 | 48,778 | 47,946 |
| Deferred Revenues | 1,242 | 693 | 640 | 883 | 803 |
| Other Non-Current Liabilities | 3,907 | 5,552 | 5,210 | 3,638 | 3,646 |
| TOTAL | $111,014 | $100,272 | $80,551 | $70,586 | $68,549 |
| Total Liabilities | $136,695 | $127,266 | $108,337 | $96,887 | $90,873 |
| Shareholders' Equity | |||||
| Common Shares | 450,928 | 456,955 | 443,671 | 454,864 | 377,975 |
| Retained earnings | -482,850 | -454,884 | -417,853 | -399,981 | -357,928 |
| Other shareholders' equity | 87,973 | 79,997 | 72,333 | 67,932 | 64,368 |
| TOTAL | $69,653 | $95,626 | $110,643 | $137,724 | $96,381 |
| Total Liabilities And Equity | $206,348 | $222,892 | $218,980 | $234,611 | $187,255 |